Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-11-14 4:11 pm Sale |
2024-02-22 | 13G | Lexaria Bioscience Corp. LEXX |
Invenomic Capital Management LP | 567,650 4.700% |
-164,331 (-22.45%) |
Filing History |
| 2024-02-14 12:00 pm Purchase |
2023-12-31 | 13G | Lexaria Bioscience Corp. LEXX |
Invenomic Capital Management LP | 731,981 7.120% |
258,878 (+54.72%) |
Filing History |
| 2024-02-14 12:00 pm Sale |
2023-12-31 | 13G | Unifi, Inc. UFI |
Invenomic Capital Management LP | 813,753 4.490% |
-130,537 (-13.82%) |
Filing History |
| 2024-02-14 12:00 pm Sale |
2023-12-31 | 13G | Viant Technology Inc. DSP |
Invenomic Capital Management LP | 439,371 2.830% |
-364,019 (-45.31%) |
Filing History |
| 2023-02-10 4:26 pm Purchase |
2022-12-31 | 13G | Unifi, Inc. UFI |
Invenomic Capital Management LP | 944,290 5.240% |
944,290 (New Position) |
Filing History |
| 2023-02-10 4:17 pm Purchase |
2022-12-31 | 13G | Viant Technology Inc. DSP |
Invenomic Capital Management LP | 803,390 5.640% |
803,390 (New Position) |
Filing History |
| 2023-02-10 4:06 pm Purchase |
2022-12-31 | 13G | Lexaria Bioscience Corp. LEXX |
Invenomic Capital Management LP | 473,103 7.950% |
113,990 (+31.74%) |
Filing History |
| 2022-03-10 4:00 pm Sale |
2022-02-28 | 13G | Immersion Corporation IMMR |
Invenomic Capital Management LP | 1,669,161 4.980% |
-29,394 (-1.73%) |
Filing History |
| 2022-02-11 5:46 pm Purchase |
2021-12-31 | 13G | Immersion Corporation IMMR |
Invenomic Capital Management LP | 1,698,555 5.140% |
1,698,555 (New Position) |
Filing History |
| 2022-02-11 5:33 pm Purchase |
2021-12-31 | 13G | Lexaria Bioscience Corp. LEXX |
Invenomic Capital Management LP | 359,113 6.030% |
359,113 (New Position) |
Filing History |